Lophos Holdings Inc. (MESC.CN)

0.0500 -0.0050 (-9.09%) As of 01:08PM EDT. Market open.

Lophos Holdings Inc.

550 Burrard St.
Suite 2900
Vancouver, BC V6C 0A3
Canada

https://lophos.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Jacqueline Claire Lupo	CEO, President & Director	217.43k	N/A	1987
Mr. Remantra Sheopaul	CFO & Corporate Secretary	7.95k	N/A	1988

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Lophos Holdings Inc., through its subsidiary, Lophos Pharmaceuticals Corp. focuses on the cultivation and research of peyote cactus. It researches and sells compounds within the peyote cactus, including mescaline for drug development. The company is headquartered in Vancouver, Canada.

Corporate Governance

Lophos Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.